Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026 Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has achieved a significant milestone by receiving Good Manufacturing Practices (GMP) certification from
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial Revolution Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has achieved a significant milestone in workforce development by
Granules' Ambitious Climate Targets Span Near-Term, Long-Term, and Net-Zero Goals, Aligned with the 1.5°C Pathway Granules India Limited, a leading global pharmaceutical company, has received validation and approval from the Science Based Targets initiative (SBTi) for its near-term, long-term, and net-zero goals. These targets, aligned with the
The report provides perspectives on the Indian market, key trends that are shaping its future and the role Global Pharma companies have been played in unlocking quality healthcare. India remains a hub of innovation and a global economic bright spot. Proactive efforts by the
Under the Production Linked Incentive (PLI) scheme, Lyfius Pharma Private Limited (Lyfius Pharma) invested ₹2,500 crores in Penicillin-G (Pen-G) facility Commercial production to ramp up in FY25, enhancing domestic production of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs) Lyfius Pharma
Mankind Pharma, a reputed global pharmaceutical firm, executed a Business Transfer Agreement (BTA) to transfer its Over-the-Counter (OTC) business undertaking to its wholly owned subsidiary, Mankind Consumer Products Private Limited (MCPPL), on a slump sale basis. In Q1 FY25, the OTC business reported revenues of
Global pharmaceutical company having a surgical business concept incepted in Dubai a global pharmaceutical having a surgical business concept incepted in Dubai, is setting its footprints in India’s Ophthalmology market with the highest ethics, top development, and uttermost safety standards!! Here, the values are extraordinary, and
ACG, a leading supplier of fully integrated manufacturing solutions to the global pharmaceutical and nutraceutical industry, is pleased to announce the appointment of Mr. Udit K Singh as the new Chief Executive Officer (CEO) of its Inspection division. Mr. Singh will be supporting the company as
